US Patent Issued to SCHRODINGER on June 30 for "Tricyclic compounds useful in the treatment of cancer, autoimmune and inflammatory disorders" (New York Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,667,572, issued on June 30, was assigned to SCHRODINGER INC. (New York).

"Tricyclic compounds useful in the treatment of cancer, autoimmune and inflammatory disorders" was invented by Shulu Feng (New York), Morgan Lawrenz (New York), Jiaye Guo (New York), Goran Krilov (New York), Andrew Placzek (New York), Zhe Nie (New York), Lynnie Trzoss (New York), Haifeng Tang (New York), Pieter Harm Bos (New York), Michael Trzoss (New York) and Shelby Ellery (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present application relates to compounds of Formula (I), as defined herein, and pharmaceutically acceptable salts thereof. The present application al...